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Controlling and preventing infections require deep under-
standing of the complex interplay that occurs between the
host and pathogen following infection. In essence, immuno-
modulation is any process leading to an immune response
that can be altered to a desired level. In mammals, the
immune system has developed an extensive array of cells
and immunomodulators to recognize, identify, and eliminate
foreign invaders. On the other hand, pathogens have evolved
multiple mechanisms to combat the host immune system
as they establish infections. In this context and under certain
circumstances, an infection may result in a subverted
immune system, which may lead to an exacerbated illness.
Recent advances in biotechnology have enhanced our knowl-
edge of the complex interplay that occurs between the host
and invading pathogens following infection, through under-
standing of the microbial virulence strategies as well as the
host’s approaches to combat the infection.
This special issue collects six high-quality papers, four
research articles and two reviews, related to understanding
immunomodulation in the context of viral and parasitic
infections.
In the article titled “Taenia crassiceps-Excreted/Secreted
Products Induce a Defined MicroRNA Profile that Modu-
lates Inflammatory Properties of Macrophages” by D.
Martínez-Saucedo et al., the authors described how Taenia
crassiceps-excreted/secreted antigens (TcES) can modulate
proinflammatory responses in macrophages by inducing reg-
ulatory posttranscriptional mechanisms and, hence, reduce
detrimental outcomes in hosts running with inflammatory
diseases. In summary, their study demonstrates a role for
TcES in regulating the production of key inflammatory cyto-
kines, “possibly by inducing microRNAs that target inflam-
matory transcripts and promoting the release of IL-10 in
macrophages.” This phenomenon shapes the transcriptomic
profile of macrophages and consequently the outcome of
the immune response. These findings increase the basic
understanding of how the released molecules from helminths
would regulate inflammation and, thus, may offer new
approaches for the treatment of autoimmune and inflamma-
tory diseases.
The remaining three research articles focused on viral
infections of three different families, namely, the lympho-
cytic choriomeningitis virus (LCMV), human papillomavi-
rus type 16, and MERS-coronavirus. The first of these
studies was titled “Lymphocytic Choriomeningitis Virus
Infection Demonstrates Higher Replicative Capacity and
Decreased Antiviral Response in the First-Trimester Pla-
centa” by E. A. L. Enninga and R. N. Theiler from the
University of Texas Medical Branch. LCMV is a zoonotic
pathogen, of which rodents are the natural reservoir.
Although the majority of persons infected with LCMV
show relatively minor illness, nonetheless, the virus can
cross the placental barrier during pregnancy and cause
congenital defects in fetuses. In this study, differences in
immunomodulation between the first- and third-trimester
placental explants infected with LCMV were evaluated.
Hindawi
Journal of Immunology Research
Volume 2019, Article ID 9710910, 2 pages
https://doi.org/10.1155/2019/9710910
Generated data suggested that the innate immune response
to LCMV infection of the human placenta is more vigorous
in the third trimester compared to the first trimester. The
authors attributed the absence of viral replication in term
placental explants to the robust innate antiviral response in
this tissue. These findings are in agreement with clinical
observations of decreased transplacental transmission and
less severe fetal phenotypes of viral pathogens acquired in
later gestation.
In the other study titled “Human Papillomavirus Type 16
Disables the Increased Natural Killer Cells in Early Lesions of
the Cervix,” J. Zhang et al. retrospectively analyzed the
histologic pathology results of 245 women with HPV type
16 only (HPV16+) or type 18 only (HPV18+). The study
was the first on emphasizing the unique immune profiles of
the cervical microenvironment between two high-risk HPV
types. In summary, the authors indicated that more severe
lesions are found in the cervix of HPV16+ women compared
with those in HPV18+ women. Briefly, their data demon-
strated that the number of NK cells was increased but their
cytotoxic function was abnormal in an HPV16-infected
cervix. The involved mechanisms may partially explain why
HPV16 is the most likely to cause cervical cancer and may
provide new potential strategies for its clinical management.
Several serological studies indicated that the Middle East
respiratory syndrome coronavirus (MERS-CoV) has been
circulating in camels in the Arabian Peninsula for more than
two decades. However, it is still intriguing why the virus was
first detected in humans in 2012. It is worth noting that
infection with MERS-CoV could be asymptomatic or cause
mild influenza-like illness. This may suggest that the prev-
alence of MERS-CoV infections in the general population
is underestimated. The aim of the study by R. A. Al Kahlout
et al. was to evaluate the performance of various serological
assays and to estimate the seroprevalence of anti-MERS-
CoV antibodies in high- and low-risk groups in Qatar. The
paper reported low prevalence of anti-MERS antibodies in
the general population, which coincides with the low num-
ber of all reported cases by the time of their study. Impor-
tantly, serological analysis indicated high cross-reactivity
between MERS-CoV and other coronaviruses, which neces-
sities more detailed investigation of the immune responses
to coronavirus infections.
One of the two reviews in this issue by W. Zeng et al.
examined the transplantation of probiotics and fecal micro-
biota on immunomodulation. Probiotics or microbiota are
commensal/nonpathogenic microbes that provide beneficial
effects to the host through several mechanisms, including
but not limited to competitive exclusion of pathogenic
bacteria and modulation of immune responses. The aim of
this review was to follow through the recent literature on
immunomodulatory effects and mechanisms of probiotics
and fecal microbiota transplantation (FMT) and also the effi-
cacy and safety of probiotics and FMT in clinical trials and
applications. The authors concluded that the immunomodu-
lation induced by probiotics is a complex interplay between
different hosts and microorganisms, and hence, the immuno-
modulatory characteristics of specific probiotics cannot be
generalized. Accordingly, “personalized probiotics interven-
tion and standardized fecal bacteria transplantation should
be challenges and prospects for future research on the inter-
vention model of intestinal flora.”
Macrophages are indispensable modulators of the innate
immune system because they maintain a delicate balance
between immunity against pathogenic bacteria and tolerance
of commensals in the intestine. In their review titled “Func-
tions of Macrophages in the Maintenance of Intestinal
Homeostasis,” S. Wang et al. focused their attention on intes-
tinal macrophages, “describing the recent insights into the
role of intestinal macrophages in maintaining gut homeosta-
sis and managing gut inflammation.” They also discussed the
nutritional modulation of intestinal macrophage functions
and the potential of nutritional strategies to manipulate
intestinal macrophages and ameliorate inflammatory bowel
disorders. They concluded that “a better understanding of
mechanisms employed by intestinal macrophages in main-
taining intestinal homeostasis and the action of enteral nutri-
ents in the regulation of intestinal macrophages will facilitate
the development of nutritional strategies in gut health
improvement as well as prevention and control of inflamma-
tory bowel disorders.”
This special issue provides original research and review
articles that would be helpful to experts and broad audience
alike in enhancing their understanding of the complex
host-pathogen interactions.
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